Management of carbapenem resistant Klebsiella pneumoniae infections in stem cell transplant recipients: An italian multidisciplinary consensus statement

Haematologica

Volumn 100, Issue 9, 2015, Pages e373-e376

  Girmenia, Corrado ^a   Viscoli, Claudio ^b   Piciocchi, Alfonso ^c   Cudillo, Laura ^d   Botti, Stefano ^e   Errico, Antonio ^f   Sarmati, Loredana ^d   Ciceri, Fabio ^g   Locatelli, Franco ^h   Giannella, Maddalena ⁱ   Bassetti, Matteo ^j   Tascini, Carlo ^k   Lombardini, Letizia ^f,l   Majolino, Ignazio ^m   Farina, Claudio ⁿ   Luzzaro, Francesco ^o   Rossolini, Gian Maria ^f,p,q   Rambaldi, Alessandro ⁿ  

^a POLICLINICO UMBERTO I   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c Fondazione GIMEMA (Gruppo Italiano Malattie EMatologiche dell'Adulto) Data Center   (Italy)

^d TOR VERGATA UNIVERSITY HOSPITAL   (Italy)

^e S MARIA NUOVA HOSPITAL   (Italy)

^f UNIVERSITY OF FLORENCE   (Italy)

^g SAN RAFFAELE HOSPITAL   (Italy)

^h UNIVERSITY OF PAVIA   (Italy)

ⁱ UNIVERSITY OF BOLOGNA   (Italy)

^j S Maria Hospital   (Italy)

^k CISANELLO HOSPITAL   (Italy)

^l ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^m Azienda Ospedaliera S   (Italy)

ⁿ Azienda Ospedaliera Papa Giovanni XXIII   (Italy)

^o Azienda Ospedaliera della Provincia di Lecco   (Italy)

^p UNIVERSITY OF SIENA   (Italy)

^q CAREGGI UNIVERSITY HOSPITAL   (Italy)

more..

Author keywords

Carbapenem resistance; Consensus; Klebsiella pneumoniae; Stem cell transplant

Indexed keywords

CARBAPENEM; COLISTIN; GENTAMICIN; POLYMYXIN B; TIGECYCLINE; CARBAPENEM DERIVATIVE;

BACTERIAL COLONIZATION; CLINICAL PROTOCOL; DISEASE TRANSMISSION; HOSPITAL INFECTION; HUMAN; INFECTION CONTROL; KLEBSIELLA PNEUMONIAE INFECTION; LETTER; PATIENT HISTORY OF STEM CELL TRANSPLANTATION; ALLOGRAFT; CLINICAL TRIAL; CONSENSUS; DRUG RESISTANCE; EPIDEMIOLOGY; HEMATOLOGIC NEOPLASMS; ITALY; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MALE; MORTALITY; MULTICENTER STUDY; STEM CELL TRANSPLANTATION;

ALLOGRAFTS; CARBAPENEMS; CONSENSUS; DRUG RESISTANCE; HEMATOLOGIC NEOPLASMS; HUMANS; ITALY; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MALE; STEM CELL TRANSPLANTATION;

EID: 84940918862     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2015.125484     Document Type: Letter

References (15)

1. Munoz-Price LS, Poirel L, Bonomo RA, et al. Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases. Lancet Infect Dis. 2013;13 (9):785-796.
2. Satlin MJ, Jenkins SG, Walsh TJ. The Global Challenge of Carbapenem-Resistant Enterobacteriaceae in Transplant Recipients and Patients With Hematologic Malignancies. Clin Infect Dis. 2014; 58(9):1274-1283
3. Pagano L, Caira M, Trecarichi EM, et al. Carbapenemase-producing Klebsiella pneumoniae and hematologic malignancies. Emerg Infect Dis. 2014;20(7):1235-1236.
4. Girmenia C, Rossolini GM, Piciocchi A, et al. Infections by carbapenem- resistant Klebsiella pneumoniae in stem cell transplant recipients: a nationwide retrospective survey from Italy. Bone Marrow Transplant. 2015;50(2):282-288.
5. Zuckerman T, Benyamini N, Sprecher H, et al. SCT in patients with carbapenem resistant Klebsiella pneumoniae: a single center experience with oral gentamicin for the eradication of carrier state. Bone Marrow Transplant. 2011;46 (9):1226-1230.
6. Tascini C, Sbrana F, Flammini S, et al. Oral gentamicin gut decontamination for prevention of KPC-producing Klebsiella pneumoniae infections: the relevance of concomitant systemic antibiotic therapy. Antimicrob Agents Chemother. 2014;58(4):1972-1976.
7. Bartoletti M, Lewis RE, Tumietto F, et al. Prospective, Cross-Sectional Observational Study of Hospitalized Patients Colonized with Carbapenemase-Resistant Klebsiella pneumoniae (CR-KP). Presented at: 23rd European Conference on Clinical Microbiology and Infectious Diseases. Berlin, Germany, 27–30 April 2013.
8. Giannella M, Trecarichi EM, De Rosa FG, et al. Risk factors for carbapenem- resistant Klebsiella pneumoniae bloodstream infection among rectal carriers: a prospective observational multicentre study. Clin Microbiol Infect. 2014;20(12):1357-1362.
9. Schwaber MJ, Lev B, Israeli A, et al. Containment of a country-wide outbreak of carbapenem-resistant Klebsiella pneumoniae in Israeli hospitals via a nationally implemented intervention. Clin Infect Dis. 2011;52(7):848-855.
10. Fournier S, Monteil C, Lepainteur M, et al. Long-term control of carbapenemase- producing Enterobacteriaceae at the scale of a large French multihospital institution: a nine-year experience, France, 2004 to 2012. Euro Surveill. 2014;19(19):20802.
11. Averbuch D, Orasch C, Cordonnier C, et al. European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European Conference on Infections in Leukemia. Haematologica. 2013; 98(12):1826-1835.
12. Averbuch D, Cordonnier C, Livermore DM, et al. Targeted therapy against multi-resistant bacteria in leukemic and hematopoietic stem cell transplant recipients: guidelines of the 4th European Conference on Infections in Leukemia (ECIL-4, 2011). Haematologica. 2013;98 (12):1836-1847.
13. Saidel-Odes L, Polachek H, Peled N, et al. A randomized, doubleblind, placebo-controlled trial of selective digestive decontamination using oral gentamicin and oral polymyxin E for eradication of carbapenem- resistant Klebsiella pneumoniae carriage. Infect Control Hosp Epidemiol. 2012;33 (1):14-19.
14. Lübbert C, Faucheux S, Becker-Rux D, et al. Rapid emergence of secondary resistance to gentamicin and colistin following selective digestive decontamination in patients with KPC-2-producing Klebsiella pneumoniae: a single-centre experience. Int J Antimicrob Agents. 2013;42(6):565-570.
15. Oren I, Sprecher H, Finkelstein R, et al. Eradication of carbapenemresistant Enterobacteriaceae gastrointestinal colonization with nonabsorbable oral antibiotic treatment: A prospective controlled trial. Am J Infect Control. 2013;41(12):1167-1172.